Approval · Notice of Compliance 5804 · 2004
BUSPAR: Notice of Compliance 5804
Issued November 8, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5804
- Date
- November 8, 2004
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anxiolytic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSPAR | 00603813 | — |
| BUSPAR | 00603821 | Cancelled Post Market |
Medicinal ingredients
- BUSPIRONE HCL 5 MG per TAB
- BUSPIRONE HCL 10 MG per TAB